Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 289-296

  Steffensen, Inger Lise ^a   Alexander, Jan ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

A J; AKR J; Differential susceptibility; Intestinal tumorigenesis; Min +; C57BL 6J; Mouse strains; PhIP

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER LOCALIZATION; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE CANCER; STRAIN DIFFERENCE;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, APC; IMIDAZOLES; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED A; MICE, INBRED AKR; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 33746268315     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.015     Document Type: Article

References (22)

1. Schut H.A.J., and Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20 (1999) 353-368
2. Moser A.R., Pitot H.C., and Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990) 322-324
3. Su L.-K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256 (1992) 668-670
4. Steffensen I.-L., Paulsen J.E., Eide T.J., and Alexander J. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 18 (1997) 1049-1054
5. Paulsen J.E., Steffensen I.-L., Andreassen Å., Vikse R., and Alexander J. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20 (1999) 1277-1282
6. Steffensen I.-L., Schut H.A.J., Paulsen J.E., Andreassen Å., and Alexander J. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res. 61 (2001) 8689-8696
7. I.-L. Steffensen, H.A.J. Schut, J. Alexander, Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo([4,5-b](pyridine (PhIP)-DNA adducts in mouse intestine and liver, Mutat. Res. 587 (2005) 73-89.
8. + allele. Mutagenesis 16 (2001) 309-315
9. Andreassen Å., Møllersen L., Vikse R., Steffensen I.-L., Mikalsen A., Paulsen J.E., et al. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Mutat. Res. 517 (2002) 157-166
10. Møllersen L., Vikse R., Andreassen Å., Steffensen I.-L., Mikalsen A., Paulsen J.E., et al. Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice. Mutat. Res. 557 (2004) 29-40
11. Moser A.R., Dove W.F., Roth K.A., and Gordon J.I. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 116 (1992) 1517-1526
12. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl Acad. Sci. USA 90 (1993) 8977-8981
13. Dietrich W.F., Lander E.S., Smith J.S., Moser A.R., Gould K.A., Luongo C., et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75 (1993) 631-639
14. 2 in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 21 (2000) 133-138
15. F.J. Ayala, J.A. Kiger Jr., Modern genetics, second ed., The Benjamin/Cummings Publishing Company Inc., Menlo Park, CA, USA, 1984, p. 839.
16. Haigis K.M., Hoff P.D., White A., Shoemaker A.R., Halberg R.B., and Dove W.F. Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function. Proc. Natl Acad. Sci. USA 101 (2004) 9769-9773
17. Min-induced intestinal neoplasia. Cell 81 (1995) 957-966
18. K.A. Silverman, R. Koratkar, L.D. Siracusa, A.M. Buchberg, Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-driven intestinal neoplasia, Genome Res. 12 (2002) 88-97.
19. Min intestinal tumorigenesis, Genomics 84 (2004) 844-852.
20. s mice, Proc. Natl Acad. Sci. USA 102 (2005) 2868-2873.
21. 2 gene alterations in human colorectal cancer, Cancer Res. 55 (1995) 5184-5186.
22. 2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients, Cancer Res. 58 (1998) 500-503.